BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1003 related articles for article (PubMed ID: 28815282)

  • 1. Correction of vitamin D status by calcidiol: pharmacokinetic profile, safety, and biochemical effects on bone and mineral metabolism of daily and weekly dosage regimens.
    Minisola S; Cianferotti L; Biondi P; Cipriani C; Fossi C; Franceschelli F; Giusti F; Leoncini G; Pepe J; Bischoff-Ferrari HA; Brandi ML
    Osteoporos Int; 2017 Nov; 28(11):3239-3249. PubMed ID: 28815282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcifediol (25-hydroxyvitamin D) improvement and calcium-phosphate metabolism of alendronate sodium/vitamin D
    Liao EY; Zhang ZL; Xia WB; Lin H; Cheng Q; Wang L; Hao YQ; Chen DC; Tang H; Peng YD; You L; He L; Hu ZH; Song CL; Wei F; Wang J; Zhang L
    BMC Musculoskelet Disord; 2018 Jul; 19(1):210. PubMed ID: 29970059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D
    Navarro-Valverde C; Sosa-Henríquez M; Alhambra-Expósito MR; Quesada-Gómez JM
    J Steroid Biochem Mol Biol; 2016 Nov; 164():205-208. PubMed ID: 26829558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcidiol [25(OH)D3]: from diagnostic marker to therapeutical agent.
    Brandi ML; Minisola S
    Curr Med Res Opin; 2013 Nov; 29(11):1565-72. PubMed ID: 24020910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of isolated vitamin D supplementation on bone turnover markers in younger postmenopausal women: a randomized, double-blind, placebo-controlled trial.
    Nahas-Neto J; Cangussu LM; Orsatti CL; Bueloni-Dias FN; Poloni PF; Schmitt EB; Nahas EAP
    Osteoporos Int; 2018 May; 29(5):1125-1133. PubMed ID: 29450585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Vitamin D Insufficiency in Postmenopausal Women: A Randomized Clinical Trial.
    Hansen KE; Johnson RE; Chambers KR; Johnson MG; Lemon CC; Vo TN; Marvdashti S
    JAMA Intern Med; 2015 Oct; 175(10):1612-21. PubMed ID: 26237520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency.
    Giusti A; Barone A; Pioli G; Girasole G; Razzano M; Pizzonia M; Pedrazzoni M; Palummeri E; Bianchi G
    J Am Geriatr Soc; 2010 Aug; 58(8):1489-95. PubMed ID: 20646099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D supplementation and bone turnover in advanced heart failure: the EVITA trial.
    Zittermann A; Ernst JB; Prokop S; Fuchs U; Dreier J; Kuhn J; Berthold HK; Pilz S; Gouni-Berthold I; Gummert JF
    Osteoporos Int; 2018 Mar; 29(3):579-586. PubMed ID: 29260292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-response effects of supplementation with calcifediol on serum 25-hydroxyvitamin D status and its metabolites: A randomized controlled trial in older adults.
    Vaes AMM; Tieland M; de Regt MF; Wittwer J; van Loon LJC; de Groot LCPGM
    Clin Nutr; 2018 Jun; 37(3):808-814. PubMed ID: 28433267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two different vitamin D supplementation regimens with oral calcifediol in kidney transplant patients.
    Barros X; Rodríguez NY; Fuster D; Rodas L; Esforzado N; Mazza A; Rubello D; Campos F; Tapias A; Torregrosa JV
    J Nephrol; 2016 Oct; 29(5):703-9. PubMed ID: 26454858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D supplementation in older people (VDOP): Study protocol for a randomised controlled intervention trial with monthly oral dosing with 12,000 IU, 24,000 IU or 48,000 IU of vitamin D₃.
    Schoenmakers I; Francis RM; McColl E; Chadwick T; Goldberg GR; Harle C; Yarnall A; Wilkinson J; Parker J; Prentice A; Aspray T
    Trials; 2013 Sep; 14():299. PubMed ID: 24041337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [High prevalence of vitamin D deficiency in postmenopausal women at a rheumatology office in Madrid. Evaluation of 2 vitamin D prescription regimens].
    Aguado P; Garcés MV; González Casaús ML; del Campo MT; Richi P; Coya J; Torrijos A; Gijón J; Martín Mola E; Martínez ME
    Med Clin (Barc); 2000 Mar; 114(9):326-30. PubMed ID: 10786331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃.
    Rossini M; Gatti D; Viapiana O; Fracassi E; Idolazzi L; Zanoni S; Adami S
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E622-6. PubMed ID: 22298802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease.
    Strugnell SA; Sprague SM; Ashfaq A; Petkovich M; Bishop CW
    Am J Nephrol; 2019; 49(4):284-293. PubMed ID: 30878999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological effects of various regimes of 25-hydroxyvitamin D3 (calcidiol) administration on bone mineral metabolism in postmenopausal women.
    Cavalli L; Cavalli T; Marcucci G; Falchetti A; Masi L; Brandi ML
    Clin Cases Miner Bone Metab; 2009 May; 6(2):169-73. PubMed ID: 22461169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.
    Matias PJ; Jorge C; Ferreira C; Borges M; Aires I; Amaral T; Gil C; Cortez J; Ferreira A
    Clin J Am Soc Nephrol; 2010 May; 5(5):905-11. PubMed ID: 20203163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of different doses and time intervals of oral vitamin D supplementation with or without calcium in elderly nursing home residents.
    Chel V; Wijnhoven HA; Smit JH; Ooms M; Lips P
    Osteoporos Int; 2008 May; 19(5):663-71. PubMed ID: 17874029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.